{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:17:28Z","timestamp":1788985048759,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172647"],"award-info":[{"award-number":["82172647"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tstp20221158"],"award-info":[{"award-number":["tstp20221158"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202312338"],"award-info":[{"award-number":["tsqn202312338"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH368"],"award-info":[{"award-number":["ZR2023QH368"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH528"],"award-info":[{"award-number":["ZR2023QH528"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2026ZD0553200-2026ZD0553203"],"award-info":[{"award-number":["2026ZD0553200-2026ZD0553203"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.redox.2026.104342","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:43:27Z","timestamp":1786059807000},"page":"104342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hypoxia drives ferroptosis resistance and immunosuppression in hepatocellular carcinoma by inducing UBASH3B-mediated glutamine metabolism reprogramming and CXCL8 expression"],"prefix":"10.1016","volume":"96","author":[{"given":"Guo-Qiang","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Ru","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2026.104342_bib1","first-page":"167","article-title":"Tumour hypoxia in driving genomic instability and tumour evolution","volume":"25","author":"Suvac","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2026.104342_bib2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.trecan.2025.08.006","article-title":"Optimizing mitochondria function in immune cells: implications for cancer immunotherapy","volume":"11","author":"Li","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.redox.2026.104342_bib3","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231106","article-title":"Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer","volume":"222","author":"Robles-Ote\u00edza","year":"2025","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.redox.2026.104342_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41571-026-01128-z","article-title":"Translating ferroptosis into oncology: challenges, opportunities and future directions","volume":"23","author":"Kang","year":"2026","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.redox.2026.104342_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156304","article-title":"Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response","volume":"170","author":"Pan","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.redox.2026.104342_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-023-02925-5","article-title":"Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment","volume":"43","author":"Hua","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.redox.2026.104342_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-025-02869-z","article-title":"Hypoxia-induced USP13 expression drives ferroptosis resistance and tumor immune evasion in hepatocellular carcinoma through the stabilization of ACLY","volume":"12","author":"Hu","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.redox.2026.104342_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202503869","article-title":"Targeted GPX4 degradation mediated by hypoxia-overcoming Nano-PDTACs for synergistic ferroptosis-immunotherapy","volume":"15","author":"Ji","year":"2026","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.redox.2026.104342_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13046-025-03511-7","article-title":"Investigating the role of UBASH3B in cancer: structural relevance, physiological functions, and therapeutic possibilities","volume":"44","author":"Werner","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.redox.2026.104342_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13046-024-03181-x","article-title":"UBASH3B-mediated MRPL12 Y60 dephosphorylation inhibits LUAD development by driving mitochondrial metabolism reprogramming","volume":"43","author":"Ji","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.redox.2026.104342_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-025-02314-w","article-title":"Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response","volume":"24","author":"Zeng","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.redox.2026.104342_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.31076","article-title":"TMPRSS4 drives angiogenesis in hepatocellular carcinoma by promoting HB-EGF expression and proteolytic cleavage","volume":"72","author":"Dong","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2026.104342_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41419-025-07356-y","article-title":"Endoplasmic reticulum stress-related super enhancer promotes epithelial-mesenchymal transformation in hepatocellular carcinoma through CREB5 mediated activation of TNC","volume":"16","author":"Wang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2026.104342_bib14","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41467-022-28618-9","article-title":"Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2026.104342_bib15","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1002\/1878-0261.13305","article-title":"Loss of GABARAPL1 confers ferroptosis resistance to cancer stem-like cells in hepatocellular carcinoma","volume":"16","author":"Du","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.redox.2026.104342_bib16","article-title":"Hypoxia promotes epithelial--mesenchymal transition of hepatocellular carcinoma cells via inducing GLIPR-2 expression","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104342_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-07974-8","article-title":"CircRNA ZFR promotes cell progression by regulating miR-96a-5p\/SLC1A1 axis in hepatocellular carcinoma","volume":"15","author":"Bongolo","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104342_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41375-019-0535-4","article-title":"Integrative phosphoproteome and interactome analysis of the role of Ubash3b in BCR-ABL signaling","volume":"34","author":"Cutler","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.redox.2026.104342_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.redox.2026.104342_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2017.10.005","article-title":"Advances in hypoxia-inducible factor biology","volume":"27","author":"Choudhry","year":"2018","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.redox.2026.104342_bib21","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cmet.2026.06.001","article-title":"The metabolic basis of regulated cell death","volume":"38","author":"Liu","year":"2026","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.redox.2026.104342_bib22","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","article-title":"Exploiting ferroptosis vulnerabilities in cancer","volume":"26","author":"Nakamura","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.redox.2026.104342_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1053\/j.gastro.2024.05.005","article-title":"Emerging trends in gastrointestinal cancer targeted therapies: harnessing tumor microenvironment, immune factors, and metabolomics insights","volume":"167","author":"Rauth","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2026.104342_bib24","article-title":"Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis","volume":"6","author":"Shen","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.redox.2026.104342_bib25","article-title":"Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor ROR\u03b3 represents an effective therapeutic opportunity in osteosarcoma","volume":"5","author":"Zheng","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.redox.2026.104342_bib26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1126\/science.adf4154","article-title":"Autoregulatory control of mitochondrial glutathione homeostasis","volume":"382","author":"Liu","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.redox.2026.104342_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2023.12.008","article-title":"Dual regulation of SLC25A39 by AFG3L2 and iron controls mitochondrial glutathione homeostasis","volume":"84","author":"Shi","year":"2024","journal-title":"Mol Cell."},{"key":"10.1016\/j.redox.2026.104342_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11033-023-09019-7","article-title":"Identification of MYB gene family in medicinal tea tree Melaleuca alternifolia (Maiden and Betche) cheel and analysis of members regulating terpene biosynthesis","volume":"51","author":"Zhang","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.redox.2026.104342_bib29","doi-asserted-by":"crossref","first-page":"D261","DOI":"10.1093\/nar\/gkr1122","article-title":"PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse","volume":"40","author":"Hornbeck","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.redox.2026.104342_bib30","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/sj.onc.1203618","article-title":"Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway","volume":"19","author":"Charrasse","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.redox.2026.104342_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bcmd.2007.04.006","article-title":"B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: implications for cell survival","volume":"39","author":"Schwab","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.redox.2026.104342_bib32","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1091\/mbc.e17-07-0450","article-title":"Ubiquitin ligase SPSB4 diminishes cell repulsive responses mediated by EphB2","volume":"28","author":"Okumura","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.redox.2026.104342_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jmb.2010.06.017","article-title":"Structural basis for Par-4 recognition by the SPRY domain- and SOCS box-containing proteins SPSB1, SPSB2, and SPSB4","volume":"401","author":"Filippakopoulos","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.redox.2026.104342_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjae014","article-title":"Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis","volume":"16","author":"You","year":"2024","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2026.104342_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12672-024-00860-1","article-title":"GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38\/JNK MAPK pathway activation and mitochondrial apoptosis","volume":"15","author":"Zhao","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.redox.2026.104342_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.04.003","article-title":"Glutaminase inhibition impairs CD8 T cell activation in STK11-\/Lkb1-deficient lung cancer","volume":"34","author":"Best","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2026.104342_bib37","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.redox.2026.104342_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.redox.2026.104342_bib39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ymthe.2024.02.003","article-title":"Metabolic reprogramming directed by super-enhancers in tumors: an emerging landscape","volume":"32","author":"Zhou","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.redox.2026.104342_bib40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41568-023-00632-z","article-title":"Metabolic pathway analysis using stable isotopes in patients with cancer","volume":"23","author":"Bartman","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2026.104342_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175445","article-title":"Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer","volume":"134","author":"Dussold","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2026.104342_bib42","article-title":"Emerging roles of energy metabolism in ferroptosis regulation of tumor cells","volume":"8","author":"Yao","year":"2021","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.redox.2026.104342_bib43","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","article-title":"Enhancing the efficacy of Glutamine metabolism inhibitors in cancer therapy","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.redox.2026.104342_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","article-title":"Glutamine metabolism in cancer: understanding the heterogeneity","volume":"3","author":"Cluntun","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.redox.2026.104342_bib45","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41467-020-15136-9","article-title":"A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer","volume":"11","author":"Kodama","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2026.104342_bib46","article-title":"Characteristics and biomarkers of ferroptosis","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.redox.2026.104342_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101670","article-title":"Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis","volume":"36","author":"Fuhrmann","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104342_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101297","article-title":"Carbonic anhydrase 9 confers resistance to ferroptosis\/apoptosis in malignant mesothelioma under hypoxia","volume":"26","author":"Li","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104342_bib49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tins.2016.12.004","article-title":"A GluD coming-of-age story","volume":"40","author":"Yuzaki","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.redox.2026.104342_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccell.2014.12.006","article-title":"Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth","volume":"27","author":"Jin","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2026.104342_bib51","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1038\/s41388-020-1199-2","article-title":"EGFR activates GDH1 transcription to promote glutamine metabolism through MEK\/ERK\/ELK1 pathway in glioblastoma","volume":"39","author":"Yang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.redox.2026.104342_bib52","article-title":"GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K\/Akt\/mTOR pathway","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.redox.2026.104342_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2026.104342_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007974","article-title":"Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy","volume":"6","author":"Highfill","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.redox.2026.104342_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052634","article-title":"The CXCL2\/IL8\/CXCR2 pathway is relevant for brain tumor malignancy and endothelial cell function","volume":"22","author":"Urbantat","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104342_bib56","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/liv.13218","article-title":"Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma","volume":"37","author":"Chan","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.redox.2026.104342_bib57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00432-021-03627-1","article-title":"Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial","volume":"148","author":"\u00d6cal","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.redox.2026.104342_bib58","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/annonc\/mdx190","article-title":"Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients","volume":"28","author":"Sanmamed","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.redox.2026.104342_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13046-023-02614-3","article-title":"HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1\/PKM2 pathway","volume":"42","author":"Lv","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.redox.2026.104342_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117553","article-title":"LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1","volume":"243","author":"Tang","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2026.104342_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726003411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726003411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:57:52Z","timestamp":1788983872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726003411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":61,"alternative-id":["S2213231726003411"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104342","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia drives ferroptosis resistance and immunosuppression in hepatocellular carcinoma by inducing UBASH3B-mediated glutamine metabolism reprogramming and CXCL8 expression","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104342"}}